Literature DB >> 2161792

Endothelin receptor subtypes and stimulation of aldosterone secretion.

C E Gomez-Sanchez1, E N Cozza, M F Foecking, S Chiou, M W Ferris.   

Abstract

Endothelins (ETs) are 21-amino acid peptides with two disulfide bonds that have powerful vasoactive properties. We have previously shown the presence of a specific, high-affinity, saturable receptor for porcine or human endothelin (ET-1) in cultured calf zona glomerulosa cells. ET-1 was a stimulator of aldosterone secretion although not as powerful as angiotensin II. Incubations of cultured calf zona glomerulosa cells with Sarafotoxin S6b (S6b), a snake venom that has a structure highly homologous to ET-1, stimulated aldosterone secretion with a potency similar to that of ET-1. Binding of [125I]ET-1 to the adrenal receptor gave a Kd of 0.17 +/- 0.05 nM and a Bmax of 36 +/- 8.5 fmol/well (n = 4). Displacement of [125I]ET-1 by unlabeled ETs and S6b showed that the concentrations needed to displace 50% of the tracer were 0.3 nM for ET-1, 0.3 nM for ET-2, 10 nM for S6b, and 100 nM for ET-3. Binding of [125I]S6b to cultured adrenal cells revealed a receptor with a Kd of 0.05 +/- 0.01 nM and a Bmax of 8 +/- 2 fmol/well (n = 4). Displacement of [125I]S6b by unlabeled ETs and S6b showed that the concentrations needed to displace 50% of the tracer were 0.03 nM for S6b, 0.06 nM for ET-1, 0.04 nM for ET-2, and 0.05 nM for ET-3. Unlabeled ET-1 and ET-2 preferentially down-regulated the binding of [125I]ET-1, and S6b preferentially down-regulated the binding of [125I]S6b.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161792     DOI: 10.1161/01.hyp.15.6.744

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

Review 1.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

2.  Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells.

Authors:  M Kohno; K Yasunari; K Yokokawa; K Murakawa; T Horio; T Takeda
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 3.  Endothelins. Vascular actions and clinical implications.

Authors:  T Sakurai; K Goto
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

Review 4.  Aldosterone biosynthesis, regulation, and classical mechanism of action.

Authors:  Gordon H Williams
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

Review 5.  Aldosterone breakthrough from a pharmacological perspective.

Authors:  Masaki Mogi
Journal:  Hypertens Res       Date:  2022-04-14       Impact factor: 5.528

6.  Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.

Authors:  G G Mattera; A Eglezos; A R Renzetti; J Mizrahi
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

Authors:  K Ishikawa; M Ihara; K Noguchi; T Mase; N Mino; T Saeki; T Fukuroda; T Fukami; S Ozaki; T Nagase
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex.

Authors:  G Rossi; G Albertin; A Belloni; L Zanin; M A Biasolo; T Prayer-Galetti; M Bader; G G Nussdorfer; G Palù; A C Pessina
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Androgens influence microvascular dilation in PCOS through ET-A and ET-B receptors.

Authors:  Megan M Wenner; Hugh S Taylor; Nina S Stachenfeld
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-08-06       Impact factor: 4.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.